Prostate Cancer

Two New Drugs Appear To Help Slow Metastatic Disease In Bone

Published in Cancer Weekly, June 5th, 2001

Two novel drugs designed to block the spread of metastatic prostate cancer in bone appear to significantly slow clinical progression of the cancer in men.

Approximately 30% of men with prostate cancer eventually develop bone metastases. Bone metastases can cause debilitating pain and are the major cause of death in men with prostate cancer.

Researchers reported on the chemotherapies at the 37th annual meeting of the American Society of Clinical Oncology, held May 12-14, 2001, in San Francisco, California.

The first study included 244 patients with hormone-refractory prostate cancer that had spread to the bones but who did not yet...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-06-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry